AG
WST icon

Advisor Group’s West Pharmaceutical WST Stock Holding History

Advisor Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.87M Buy
19,070
+1,541
+9% +$224K 0.02% 650
2019
Q3 		$2.49M Sell
17,529
-504
-3% -$69.4K 0.02% 669
2019
Q2 		$2.26M Buy
18,033
+1,299
+8% +$153K 0.02% 708
2019
Q1 		$1.84M Buy
16,734
+4,199
+33% +$437K 0.02% 753
2018
Q4 		$1.23M Buy
12,535
+1,916
+18% +$208K 0.01% 844
2018
Q3 		$1.31M Buy
10,619
+3,511
+49% +$394K 0.01% 827
2018
Q2 		$705K Buy
7,108
+752
+12% +$69.2K 0.01% 1085
2018
Q1 		$561K Sell
6,356
-2,603
-29% -$244K 0.01% 1237
2017
Q4 		$884K Buy
8,959
+981
+12% +$96.2K 0.01% 974
2017
Q3 		$767K Sell
7,978
-18
-0.2% -$1.63K 0.01% 960
2017
Q2 		$756K Buy
7,996
+1,724
+27% +$159K 0.01% 899
2017
Q1 		$513K Buy
6,272
+228
+4% +$19.1K 0.01% 1060
2016
Q4 		$513K Buy
6,044
+1,404
+30% +$110K 0.01% 1007
2016
Q3 		$346K Buy
4,640
+915
+25% +$72.6K 0.01% 1188
2016
Q2 		$281K Buy
+3,725
New +$271K 0.01% 1228

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Advisor Group's WST Position: Q4 2019 in Review

Advisor Group increased its West Pharmaceutical (WST) stake by 8.8% in Q4 2019, buying an estimated $224K and bringing the position to 19,070 shares worth $2.87M. The position accounts for 0.02% of the portfolio, ranked #650.

Advisor Group first reported a position in WST in Q2 2016 and has held it in 15 quarters since. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

  • Advisor Group held 19,070 shares of West Pharmaceutical worth $2.87M as of Q4 2019.
  • Advisor Group bought 1,541 West Pharmaceutical shares in Q4 2019, an estimated $224K.
  • West Pharmaceutical made up 0.02% of Advisor Group's portfolio in Q4 2019, its #650 holding.
  • Advisor Group first reported a position in West Pharmaceutical in Q2 2016 and has held it in 15 quarters since.
  • 445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.